Skip to content

Clinical trials

Phase 1/2 Granulomatous Disease, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatous Disease, Chronic Phase: Phase 1/2 Country / region: United States Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20131
20141
20151
20181
20222
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Enrolling by invitation4
Recruiting2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)7
Children's Hospital Los Angeles1
Ensoma1
Paul Szabolcs1
Prime Medicine, Inc.1
University of California, Los Angeles1
University of Florida1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatous Disease, Chronic13
Wiskott-Aldrich Syndrome3
Anemia, Sickle Cell2
Common Variable Immunodeficiency2
Inflammatory Bowel Diseases2
Lymphoproliferative Disorders2
Mucopolysaccharidosis I2
Severe Combined Immunodeficiency2
Thalassemia2
Adrenoleukodystrophy1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.